The global imaging agents market is projected to reach USD 19.35 billion by 2028, growing at a CAGR of 3.9%. Increasing elderly populace suffering from end stage illness, the growing volume of CT and MRI inspections worldwide and increasing number of approvals of imaging agents are some of the factors driving the growth of the global imaging agents market.
Adroit Market Research report on global imaging agents market gives a holistic view of the market from 2018 to 2028, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic years from 2018 to 2019, with the base year of estimation as 2020 and forecast from 2021 to 2028. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global imaging agents market have been studied in detail.
The global imaging agents market is categorized based on application and end-use. On the basis of application, the market is segmented into oncology, cardiology, gastrointestinal disorders and neurology disorders. On the basis of end-use, the market is segmented into hospitals and clinics, ambulatory surgical centers, diagnostic & imaging centers, and others. In 2020, the diagnostic & imaging centers accounted for the largest share of the global imaging agents market.
North America dominated the market for imaging agents in 2020, while Asia-Pacific is set to grow at the highest CAGR due to increasing R&D investments. Key players of the global imaging agents market include General Electric Company, Piramal Imaging SA, Daiichi Sankyo Company Limited, Bracco Diagnostic Inc., Lantheus Medical Imaging Inc., Eisai Pharmaceuticals India Pvt. Ltd., Curium, Guerbet Company, Aytu BioScience Inc., Bayer Healthcare Pharmaceuticals among others.
Key segments of the global imaging agents market
Application Overview, 2018-2028 (USD Billion)
- Gastrointestinal Disorders
- Neurology Disorders
End User Overview, 2018-2028 (USD Billion)
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Diagnostic & imaging centers
Regional Overview, 2018-2028 (USD Billion)
- North America
- United Kingdom
- Asia Pacific
- South America
- Middle East & Africa
- South Africa